Simulations Plus, Inc.SLP

Market cap
$603.41M
P/E ratio
60.6x
Aug 31,
2013
Aug 31,
2014
Aug 31,
2015
Aug 31,
2016
Aug 31,
2017
Aug 31,
2018
Aug 31,
2019
Aug 31,
2020
Aug 31,
2021
Aug 31,
2022
Aug 31,
2023
Net income33456999101210
Depreciation and amortization42,57347,231211,454196,250151,444333444
Change in fair value of contingent consideration----38,188152,752109,060202,500001
Amortization of Debt Discount (Premium)--------22-1
Stock-based compensation-144,327295,243347,077585,018709,08312335
Deferred income taxes---55,91923,241178,3742299,096377,75910-
Deferred income taxes366,9861---------2
Currency translation adjustments-------58,46700-0
Loss (gain) from disposal of assets-----------0
Impairment of other intangibles----------1
Currency translation adjustments-------58,46700-0
Accounts receivable-643,771-247,456-1,048,9691876,2311-487,970224-4
Prepaid income taxes-446,786-748,359555,486-93,043-149,850452,51712,38000-1
Prepaid expenses and other assets-41,317-4,014104,83629,093-40,528153,68293,877398,2130-11
Accounts payable-31,498-15,46419,443-101,29699,337110,713-147,529220,5840-0-0
Other liabilities----------11
Deferred revenue-42,555-58,85748,57397,477-252,58227,966-29,747-81,305020
Accrued income taxes-662,427-43,602-43,602-153,713------0
Deferred revenue-42,555-58,85748,57397,477-252,58227,966-29,747-81,305020
Net cash provided by operating activities3---791211191822
Purchases of property and equipment53,15024,48671,36939,121175,961183,291137,745231,380210
Purchase of short-term investments-------6712210195
Proceeds from sale of short-term investments--------100109-
Proceeds from maturities of short-term investments----------115
Purchased intangibles-------9--1
Cash received in acquisition--190,184-2--4---
Acquisition of Immunetrics, net of cash acquired----------8
Capitalized computer software development costs11111222333
Net cash provided by (used in) investing activities-1,181,738----4,355,220-2,328,720-1,955,741-75,505,710-2747
Payment of dividends43333444555
Payments on contracts payable-------214-
Proceeds from Stock Options Exercised27,98598,62557,043182,049111,404635,583788,147629,747112
Proceeds from follow-on public offering, net-------108---
Repurchase and retirement of common shares----------20
Net cash used in financing activities-----4,337,085-3,773,485-7,647,881102-5-8-23
Net increase (decrease) in cash and cash equivalents---------12156
Income taxes paid2692,562961,90733332233
Stock issued for acquisition of Lixoft-------311-
Liabilities Assumed----6--5--6
Right of use assets capitalized-------1110